Cytopathology Case Presentation #8



Similar documents
Practical Effusion Cytology

Diagnostic Challenge. Department of Pathology,

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid

Effusions: Mesothelioma and Metastatic Cancers

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids

How To Test For Cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

How To Diagnose And Treat A Tumour In An Effusion

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

Diagnosis of Mesothelioma Pitfalls and Practical Information

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download

Carcinosarcoma of the Ovary

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin

ORIGINAL ARTICLES. Materials and Methods

ThinPrep Non-Gyn Lecture Series. Body Fluid Cytology

The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion

Pleural and Pericardial fluids a one year analysis

Update on Mesothelioma

Cytology of Malignant Mesothelioma

The Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions

Video Microscopy Tutorial 5

Case of the. Month October, 2012

The develpemental origin of mesothelium

Ber-EP4 and Anti-Calretinin Antibodies: A Useful Combination for

ALTHOUGH excellent accounts have been published in recent years of

MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT

Effusion cytology. Dr Alpha Tsui Royal Melbourne Hospital 2008

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

3-F. Pathology of Mesothelioma

Seattle. Case Presentations. Case year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

The Diagnosis of Cancer in the Pathology Laboratory

Cytopathology of Pleural Mesotheliomas

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Male. Female. Death rates from lung cancer in USA

Nilesh P. Patel, MD, 1 Cullen A. Taylor, MD, 1* Edward A. Levine, MD, 2 Jacqueline K. Trupiano, MD, 1* and Kim R. Geisinger, MD 1.

BRIEF REPORTS. Introduction

Notice of Faculty Disclosure

Académie internationale de Pathologie - Division arabe XX ème congrès novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas

Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum.

Ovarian tumors Ancillary methods

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum

Cytology of Lymph Nodes

Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma -

Use of a Panel of Markers in the Differential Diagnosis of Adenocarcinoma and Reactive Mesothelial Cells in Fluid Cytology

The Diagnostic Value of Pleural Fluid Cytology in Benign and Malignant Pleural Effusions

No Difference Between Mesothelioma and Pulmonary and Nonpulmonary Adenocarcinoma DO NOT DUPLICATE. Malignancy is a common cause of effusions of the

Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura

Materials and Methods Specimens

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

264 Diagnostic Cytopathology, Vol 38, No 4 ' 2010 WILEY-LISS, INC.

A 70-year old Man with Pleural Effusion

Immunohistochemical differentiation of metastatic tumours

ESSENTIALS OF FLUID CYTOLOGY

Lung Carcinoma. Claire W. Michael. Introduction. Epidemiology. Clinical Presentation. Diagnosis

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach

Accuracy of pleural effusion cytopathology. Fatemeh Samiee Rad

MOC-31 Exhibits Superior Reactivity Compared With Ber-EP4 in Invasive Lobular and Ductal Carcinoma of the Breast. A Tissue Microarray Study

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Case based applications part III

Case presentation. Awatif Al-Nafussi

Diagnostic Utility of MOC-31, HBME-1 and MOC-31mRNA in Distinguishing Between Carcinoma Cells and Reactive Mesothelial Cells in Pleural Effusions

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Histopathology of Major Salivary Gland Neoplasms

OBJECTIVES By the end of this segment, the community participant will be able to:

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

Case Report of Renal Cell Carcinoma Diagnosed in Voided Urine Confirmed by CD10 Immunocytochemistry

Today s Topics. Tumors of the Peritoneum in Women

Histologic Classification and Differential Diagnosis of Mesothelioma

Immunostain Update: Diagnosis of Metastatic Breast Carcinoma, Emphasizing the Distinction from Gynecologic Cancers

Pathology of lung cancer

Malignant mesothelioma of the pleura: relation

PROTOCOL OF THE RITA DATA QUALITY STUDY

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa

Lessons from a consultation practice

More than 2,500 people are diagnosed with mesothelioma in the UK each year.

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports

Malignant Mesothelioma Electron Microscopy

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic?

How To Use Calretinin

LEGENDA. -23 th, 2015 EuROPEAN CONGRESS Of CYtOLOGY. MILAN, SEPtEMbER 20. Preliminary Program at a Glance 20 th September.

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

Lymphohistiocytoid Mesothelioma An Often Misdiagnosed Variant of Sarcomatoid Malignant Mesothelioma

Silent Time-Bomb, Mesothelioma

Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium

Malignant Peritoneal Mesothelioma in Women A Study of 75 Cases With Emphasis on Their Morphologic Spectrum and Differential Diagnosis

A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma

Deciduoid Mesothelioma:

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Transcription:

Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada

Clinical History 44 year old woman presents with new onset shortness of breath

Slide 1 Pleural Effusion 200x magnification

Slide 2 Pleural Effusion 200x magnification

What is your diagnosis?

Diagnosis: Metastatic lobular carcinoma

The diagnosis of metastatic lobular carcinoma in effusion specimens Emily E. Volk, MD and Jonathan H. Hughes MD The illustrations in this presentation represent material collected from the authors as well as submitted material from the College of American Pathologists Non-Gynecologic Cytopathology Program. A common manifestation of metastatic breast cancer is pleural effusions. About 80% are ipsilateral to the primary lesion, while 10% are bilateral. Malignant effusions originating from breast carcinomas have several morphologic presentations that can be identified as one of four major patterns: cannonballs, Indian files, signet ring cells, and mesothelial pattern.

Cannonball pattern Cohesive, closely packed clusters of malignant cells Smooth borders around cell clusters Cells with even, homogenous cytoplasm Large cell clusters of suggestive of ductal rather than lobular carcinoma

Cannonball pattern of adenocarcinoma 200x magnification; Pap stain

Cannonball pattern of adenocarcinoma 400x magnification; Pap stain

Indian file pattern Indian file pattern or long chain pattern of adenocarcinoma is nearly diagnostic of breast origin Small cells in long chains with homogenous cytoplasm and relatively bland nuclei suggest lobular carcinoma Medium to larger cells in shorter chains is more commonly associated with ductal carcinoma Other malignancies that may present with chains of tumor cells within effusions include pancreatic carcinoma, gastric carcinoma, small cell carcinoma of lung, mesothelioma and carcinoid tumors.

Indian-file pattern of adenocarcinoma 400x magnification; Pap stain

Signet ring pattern Malignant cell population that has large cytoplasmic vacuoles Nucleus is compressed to the cell periphery Indentation of the nuclear membrane is characteristic Often associated with isolated tumor cells Differential diagnosis of intracytoplasmic vacuoles includes benign mesothelial cells with degenerative changes. Signet ring pattern adenocarcinoma is highly suggestive of breast (lobular carcinoma), and gastric origins. Other malignancies that may present with this pattern in pleural effusions include lymphoma, melanoma, sarcoma and mesothelioma.

Signet-ring pattern of adenocarcinoma 400x magnification; Pap stain

Mesothelial pattern Malignant tumor cells blend imperceptibly with the background benign mesothelial population. Extremely difficult to diagnose, but a relatively common pattern. Helpful diagnostic clues of malignancy include irregularly thickened nuclear membranes, extra Barr bodies, prominent nucleoli, secretory vacuoles or intracytoplasmic lumen. Mucicarmine stain may be helpful to discern nature of vacuoles as the excretion of epithelial mucin indicates malignancy.

Mesothelial pattern of adenocarcinoma 400x magnification; Pap stain

Most common sites of origin of malignant effusions 80% of malignant cells in effusions are adenocarcinomas or lymphomas Most common sites of origin of adenocarcinoma: Breast-25% Lung-23% Ovaries-17% Stomach-8% Other-27% Ovaries and stomach: usually ascites Breast and lung: usually pleural effusions

Immunocytochemistry The use of Ber-EP4, B72.3 and CEA to identify antigens native to adenocarcinoma cells and not found in mesothelial cells often assists in diagnosing difficult cases. The use of leukocyte common antigen and Ki-1 to identify antigens native to malignant lymphoma cells and not found in adenocarcinoma cells may also be useful.

Immunocytochemistry Cell block material can be very useful EMA positivity in metastatic adenocarcinoma in pleural fluid

References 1. Demay RM. The Art and Science of Cytopathology, Volume 1. ASCP Press, Chicago, p.272-273. 2. Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 585 specimens from 472 consecutive patients. Cancer. 56; 1985: 905-909. 3. Bailey ME, Brown RW, Mody DR, Cagle P, and Ramzy I. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with CEA, B72.3 and Leu-M1. Acta Cytol. 40; 1996: 1212-1216. 4. Murphy WM, Ng APB. Determination of primary site by examination of cancer cells in body fluids. Am J Clin Pathol. 58; 1972: 479-488. 5. Zakowski MF, Feiner H, Finfer M, Thomas P, Wollner N, Flippa DA. Cytology of extranodal Ki-1 anaplastic large cell lymphoma. Diagn Cytopathol. 14; 1996: 155-161.